Japan’s Health Ministry said on Thursday it has received reports of 81 deaths among cancer patients linked to use of new lung cancer drug Iressa.
The drug is made by AstraZeneca Plc, Europe’s second-largest drug maker. It was released in Japan in July for treatment of non-small-cell lung cancer.
The death toll, as of November 25, compares with the ministry’s announcement in October of 13 deaths linked to Iressa. The ministry said Iressa is not being withdrawn from the market but it plans to have experts study the cases of patients who have died or suffered side effects, and ask them to try to report back by the end of this month.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!